Concerta, the extended-release formulation of methylphenidate, plays a pivotal role in managing attention deficit hyperactivity disorder (ADHD) and narcolepsy by providing steady dopamine and norepinephrine modulation throughout the day. This osmotic-release system ensures consistent symptom control, helping individuals maintain focus and reduce impulsivity without frequent dosing. As global awareness of ADHD grows, understanding the Concerta […]